- Home
- LPTX vs AKA Comparison
LPTX vs AKA Comparison
Compare LPTX & AKA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LPTX
- AKA
- Stock Information
- Founded
- LPTX 2011
- AKA 2018
- Country
- LPTX United States
- AKA United States
- Employees
- LPTX N/A
- AKA N/A
- Industry
- LPTX Biotechnology: Biological Products (No Diagnostic Substances)
- AKA Catalog/Specialty Distribution
- Sector
- LPTX Health Care
- AKA Consumer Discretionary
- Exchange
- LPTX Nasdaq
- AKA Nasdaq
- Market Cap
- LPTX 119.6M
- AKA 110.4M
- IPO Year
- LPTX N/A
- AKA 2021
- Fundamental
- Price
- LPTX $0.33
- AKA $11.08
- Analyst Decision
- LPTX Hold
- AKA Buy
- Analyst Count
- LPTX 1
- AKA 4
- Target Price
- LPTX N/A
- AKA $22.50
- AVG Volume (30 Days)
- LPTX 3.3M
- AKA 8.6K
- Earning Date
- LPTX 08-11-2025
- AKA 08-06-2025
- Dividend Yield
- LPTX N/A
- AKA N/A
- EPS Growth
- LPTX N/A
- AKA N/A
- EPS
- LPTX N/A
- AKA N/A
- Revenue
- LPTX N/A
- AKA $586,514,000.00
- Revenue This Year
- LPTX N/A
- AKA $6.60
- Revenue Next Year
- LPTX N/A
- AKA $4.14
- P/E Ratio
- LPTX N/A
- AKA N/A
- Revenue Growth
- LPTX N/A
- AKA 8.09
- 52 Week Low
- LPTX $0.22
- AKA $7.00
- 52 Week High
- LPTX $4.79
- AKA $32.25
- Technical
- Relative Strength Index (RSI)
- LPTX 48.69
- AKA 45.23
- Support Level
- LPTX $0.28
- AKA $10.71
- Resistance Level
- LPTX $0.36
- AKA $11.59
- Average True Range (ATR)
- LPTX 0.04
- AKA 0.71
- MACD
- LPTX 0.01
- AKA -0.05
- Stochastic Oscillator
- LPTX 39.43
- AKA 33.20
About LPTX Leap Therapeutics Inc.
Leap Therapeutics Inc is in developing targeted antibody therapies for cancer treatment, focusing on inhibiting tumor-promoting pathways, targeting cancer-specific cell surface molecules, and activating the immune system against cancer cells. The company's lead program, DKN-01, targets Dickkopf-related protein 1 (DKK1) and is in clinical trials for esophagogastric, gynecologic, and colorectal cancers. Their second program, FL-301, targets Claudin18.2-expressing cells. Additionally, the company has two preclinical antibody programs, FL-302 and FL-501, aimed at developing transformative cancer treatments. Operating as a single segment, the company's sole focus is on developing innovative drugs to address unmet needs in cancer therapy. .
About AKA a.k.a. Brands Holding Corp.
a.k.a. Brands Holding Corp is an online fashion retailer focused on acquiring and accelerating the growth of next-generation, digitally native fashion brands targeting Gen Z and Millennial customers. The brands of the company are two women's brands, Princess Polly and Petal & Pup, and two streetwear brands, Culture Kings and mnml. The company derives maximum revenue from Australia/New Zealand.